Ovarian Cancer Myths Debunked
Ovarian CancerYour Guide to Managing Ovarian Cancer

Ovarian Cancer Myths vs. Facts

The best way to beat ovarian cancer is to know the difference between misconceptions and the facts. Check out these 6 debunked myths.
Ovarian Cancer Myths vs. Facts
Maryna Terletska/Getty Images
By
Updated on May 19, 2025
by
Ovarian cancer is historically known as a silent killer, because many of its early symptoms, such as bloating and constipation, often aren’t associated with severe illness. Ovarian cancer is diagnosed in nearly 21,000 American women each year, but it’s often detected at a later, less treatable stage.

Beyond its reputation, though, there are also a lot of misconceptions, says David A. Fishman, MD, a gynecologic oncologist and the director of the cancer center at NewYork-Presbyterian Weill Cornell Medicine in New York City.

Here, Dr. Fishman sifts through some of the myths regarding the disease.

Myth 1: Ovarian Cancer Symptoms Can Mask Others

The discomfort of ovarian cancer is real, not vague. It’s more that you can mistake symptoms for other things. “Since your ovaries are surrounded by your bowels and colon, you may think you’re having digestive issues, for instance, if you’re experiencing pelvic pain,” Fishman explains. The solution is to always consider the possibility that the discomfort could be coming from your ovaries. Any pelvic discomfort or pain that lasts for more than a few days should be evaluated, he says. “During an appointment with any healthcare provider, whether it’s your gynecologist or your [gastroenterologist], make sure you ask to have your ovaries evaluated, too.”

Myth 2: There’s No Way to Prevent Ovarian Cancer

There’s no surefire way to prevent ovarian cancer, says Fishman, but there are certain things you can do to help prevent it. “For example, five years’ use of birth control pills can decrease your risk by 50 percent, even among women who have a mutation like BRCA1 or BRCA2 that increases the risk of developing ovarian cancer,” he says. “If you’re not trying to get pregnant, taking birth control pills for five years can help.”

Myth 3: There’s No Definitive Way to Screen for Early Stage Ovarian Cancer

Actually, an ultrasound can pick up an ovarian mass quite well. The catch: Ultrasounds are not used as a screening tool, because the disease is relatively rare and the tests are expensive. “Ultrasounds are the best imaging we have to evaluate the ovaries,” Fishman says. But because it costs a lot to screen so many women, insurance companies have yet to offer them as part of routine preventive care, he explains.

There’s another reason ultrasounds are not routinely performed to detect ovarian cancer, according to the American Cancer Society. Studies of women at average risk of ovarian cancer found that using ultrasound for screening led to more testing — and in some cases, surgeries — but failed to lower the number of deaths due to ovarian cancer.

Myth 4: Women With the BRCA1 or BRCA2 Mutation Have the Highest Ovarian Cancer Risk

Yes and no. The lifetime risk of being diagnosed with ovarian cancer is less than 2 percent for those who do not have a high-risk mutation. For women with the BRCA1 mutation, the average cumulative risk is 35 percent, and for women with BRCA 2, the risk is 10 to 30 percent. But that’s not the whole story. Experts are learning more and more about inherited mutations, as well as acquired mutations. “For example, you can be born without a mutation, but you can be exposed to environmental toxins that cause you to develop one,” says Fishman. “Ultimately, all cancers are due to genetics, but not all genetic mutations are inherited; some are acquired. It’s unique to you.”

Myth 5: The CA-125 Blood Test Is a Useful Blood Test for Detecting Ovarian Cancer

Not really. Doctors sometimes use this blood test, which measures the amount of a protein called CA-125 in the blood, as a first-pass screening to detect the potential presence of ovarian cancer. But it was never intended to be a diagnostic test, Fishman notes. “There are many different types of ovarian cancer,” he says. “Some types don’t produce that protein. So, its ability to detect early stage ovarian cancer is less than 50 percent.” It is useful, though, when tracking the status of disease in some people who have already been diagnosed. “That’s what it’s approved for,” says Fishman.

Myth 6: Ovarian Cancer Is All About the Ovaries

Not necessarily. There are actually some strong theories that ovarian cancers start in the fallopian tubes and spread to the ovaries, but the connection remains uncertain, says Fishman. He is currently studying whether detecting precancers in the fallopian tubes and treating them will deter ovarian cancer from developing.


The Takeaway

  • Ovarian cancer, which is marked by seemingly benign early symptoms, such as bloating and constipation, is often misunderstood.
  • Some myths persist, such as that ovarian cancer starts only in the ovaries (when, in fact, it may begin in the fallopian tubes) and there’s no way to reduce your risk of developing the disease.
  • By reading the facts behind the myths about ovarian cancer, you can learn more about how this disease is detected and treated today.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Key Statistics for Ovarian Cancer. American Cancer Society. January 16, 2025.
  2. Can Ovarian Cancer Be Found Early? American Cancer Society. July 24, 2020.
  3. Can Ovarian Cancer Be Prevented? American Cancer Society. April 11, 2018.
  4. Ovarian Cancer Risk Factors. American Cancer Society. April 30, 2025.
  5. Liberto JM et al. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers. June 2022.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network
walter-tsang-bio

Walter Tsang, MD

Medical Reviewer
Castle Connolly Top Doctor, Member of American College of Lifestyle Medicine
Walter Tsang, MD, is a board-certified medical oncologist, hematologist, and lifestyle medicine specialist. Inspired by the ancient Eastern philosophy of yang sheng ("nourishing life"), Dr. Tsang has developed a unique whole-person oncology approach that tailors cancer care and lifestyle recommendations to each patients’ biopsychosocial-spiritual circumstances. He partners with patients on their cancer journeys, emphasizing empowerment, prevention, holistic wellness, quality of life, supportive care, and realistic goals and expectations. This practice model improves clinical outcomes and reduces costs for both patients and the healthcare system. 

Outside of his busy clinical practice, Tsang has taught various courses at UCLA Center for East West Medicine, Loma Linda University, and California University of Science and Medicine. He is passionate about health education and started an online seminar program to teach cancer survivors about nutrition, exercise, stress management, sleep health, and complementary healing methods. Over the years, he has given many presentations on integrative oncology and lifestyle medicine at community events. In addition, he was the founding co-chair of a lifestyle medicine cancer interest group, which promoted integrative medicine education and collaborations among oncology professionals.

Tsang is an active member of American Society of Clinical Oncology, Society for Integrative Oncology, and American College of Lifestyle Medicine. He currently practices at several locations in Southern California. His goal is to transform cancer care in the community, making it more integrative, person-centered, cost-effective and sustainable for the future.
See full bio
lambeth-hochwald-bio

Lambeth Hochwald

Author

Lambeth Hochwald is an experienced freelance journalist whose work has appeared in CNN, New York Post, Prevention, Parade, Women's Health, Men's Health, and Woman's Day. She strives to bring humanity into all of her work, particularly real profiles and stories. She specializes in breast and ovarian cancer. When she isn't writing, she is teaching the next generation of journalists at NYU.

See full bio
See Our Editorial PolicyMeet Our Health Expert Network